Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 29-10-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Turning Point Therapeutics Offering of Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised the joint book-running managers in connection with a USD460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock was listed on the Nasdaq Global Select Market under the symbol TPTX.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Lead Manager | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Alan F Denenberg |
